In periodontitis, down-regulation of LRP5 results in the loss of alveolar bone and increases inflammation through the blockade of the PI3K/c-FOS signaling pathway, suggesting that LRP5 could be a promising target therapy for this disease [84]. This evidence concerns the gene LRP5 and periodontitis.